Menu
GeneBe

rs144692954

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004281.4(BAG3):​c.1138C>T​(p.Pro380Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000742 in 1,614,136 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P380L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0031 ( 2 hom., cov: 31)
Exomes 𝑓: 0.00050 ( 7 hom. )

Consequence

BAG3
NM_004281.4 missense

Scores

2
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:16

Conservation

PhyloP100: 1.02
Variant links:
Genes affected
BAG3 (HGNC:939): (BAG cochaperone 3) BAG proteins compete with Hip for binding to the Hsc70/Hsp70 ATPase domain and promote substrate release. All the BAG proteins have an approximately 45-amino acid BAG domain near the C terminus but differ markedly in their N-terminal regions. The protein encoded by this gene contains a WW domain in the N-terminal region and a BAG domain in the C-terminal region. The BAG domains of BAG1, BAG2, and BAG3 interact specifically with the Hsc70 ATPase domain in vitro and in mammalian cells. All 3 proteins bind with high affinity to the ATPase domain of Hsc70 and inhibit its chaperone activity in a Hip-repressible manner. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004340023).
BP6
Variant 10-119676692-C-T is Benign according to our data. Variant chr10-119676692-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 162782.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-119676692-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00307 (467/152246) while in subpopulation AFR AF= 0.0102 (425/41538). AF 95% confidence interval is 0.00943. There are 2 homozygotes in gnomad4. There are 197 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 467 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
BAG3NM_004281.4 linkuse as main transcriptc.1138C>T p.Pro380Ser missense_variant 4/4 ENST00000369085.8
BAG3XM_005270287.2 linkuse as main transcriptc.1135C>T p.Pro379Ser missense_variant 4/4

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
BAG3ENST00000369085.8 linkuse as main transcriptc.1138C>T p.Pro380Ser missense_variant 4/41 NM_004281.4 P1
BAG3ENST00000450186.1 linkuse as main transcriptc.961C>T p.Pro321Ser missense_variant 5/55

Frequencies

GnomAD3 genomes
AF:
0.00307
AC:
467
AN:
152128
Hom.:
2
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0103
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00269
Gnomad FIN
AF:
0.000283
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00126
AC:
318
AN:
251448
Hom.:
2
AF XY:
0.00107
AC XY:
145
AN XY:
135906
show subpopulations
Gnomad AFR exome
AF:
0.0119
Gnomad AMR exome
AF:
0.000318
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00323
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.0000615
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000499
AC:
730
AN:
1461890
Hom.:
7
Cov.:
79
AF XY:
0.000523
AC XY:
380
AN XY:
727248
show subpopulations
Gnomad4 AFR exome
AF:
0.0118
Gnomad4 AMR exome
AF:
0.000470
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000504
Gnomad4 SAS exome
AF:
0.00263
Gnomad4 FIN exome
AF:
0.000168
Gnomad4 NFE exome
AF:
0.0000180
Gnomad4 OTH exome
AF:
0.000811
GnomAD4 genome
AF:
0.00307
AC:
467
AN:
152246
Hom.:
2
Cov.:
31
AF XY:
0.00265
AC XY:
197
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.0102
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000193
Gnomad4 SAS
AF:
0.00290
Gnomad4 FIN
AF:
0.000283
Gnomad4 NFE
AF:
0.0000147
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00128
Hom.:
0
Bravo
AF:
0.00341
ESP6500AA
AF:
0.0109
AC:
48
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00148
AC:
180
Asia WGS
AF:
0.00404
AC:
14
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:7
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 19, 2012p.Pro380Ser in Exon 04 of BAG3: This variant is not expected to have clinical si gnificance because it has been identified in 1.0% (39/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs144692954). -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Aug 18, 2016- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
not provided Benign:4
Benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpAug 04, 2017Variant summary: The BAG3 c.1138C>T (p.Pro380Ser) variant involves the alteration of a non-conserved nucleotide. 2/3 in silico tools predict a benign outcome for this variant (SNPsandGO not captured due to low reliability index). This variant was found in 180/121378 control chromosomes (2 homozygotes) from ExAC, predominantly observed in the African subpopulation at a frequency of 0.010959 (114/10402). This frequency is about 281 times the estimated maximal expected allele frequency of a pathogenic BAG3 variant (0.0000391), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. In addition, multiple clinical diagnostic laboratories in ClinVar have classified this variant as benign. The variant of interest has not, to our knowledge, been reported in affected individuals in literature. Taken together, this variant is classified as benign. -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 16, 2023- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 09, 2018This variant is associated with the following publications: (PMID: 27896284, 21459883) -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJul 22, 2016- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioMay 16, 2023- -
Myofibrillar myopathy 6 Benign:1
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Atrial fibrillation Benign:1
Benign, criteria provided, single submitterclinical testingCenter for Advanced Laboratory Medicine, UC San Diego Health, University of California San DiegoApr 17, 2019- -
Myofibrillar myopathy 6;C3151293:Dilated cardiomyopathy 1HH Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsOct 20, 2015This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Benign
0.060
T;T
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.17
FATHMM_MKL
Benign
0.44
N
LIST_S2
Benign
0.81
T;T
MetaRNN
Benign
0.0043
T;T
MetaSVM
Benign
-0.78
T
MutationAssessor
Uncertain
2.5
M;.
MutationTaster
Benign
0.83
D
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.49
N;N
REVEL
Benign
0.13
Sift
Benign
0.18
T;D
Sift4G
Benign
0.40
T;D
Polyphen
0.17
B;.
Vest4
0.70
MVP
0.86
MPC
0.069
ClinPred
0.0063
T
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.032
gMVP
0.38

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144692954; hg19: chr10-121436204; API